Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Sanofi”

Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s)Terminated
NCT03713684Phase 3Updated Dec 2, 2021
Sponsor: Sanofi
Type 2 Diabetes Mellitus
United States, China, South Korea
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With SulfonylureaTerminated
NCT03770728Phase 3Updated Dec 2, 2021
Sponsor: Sanofi
Type 2 Diabetes Mellitus
United States, China, Taiwan
Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus CancerCompleted
NCT00193128Phase 1, Phase 2Updated Nov 24, 2021
Sponsor: SCRI Development Innovations, LLC
Esophagus Cancer
United States
A Safety and Immune Response Study of 2 Experimental HIV VaccinesCompleted
NCT02404311Phase 1, Phase 2Updated Nov 5, 2021
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infection
South Africa
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With MetforminTerminated
NCT03684642Phase 3Updated Nov 1, 2021
Sponsor: Sanofi
Type 2 Diabetes Mellitus
United States, Hungary, Poland, Ukraine
Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic DermatitisTerminated
NCT03736967Phase 2Updated Nov 1, 2021
Sponsor: Regeneron Pharmaceuticals
Atopic Dermatitis
United States, Belgium, Czechia, Germany, Poland +2 more
Trastuzumab and Oxaliplatin in Patients With Metastatic Breast CancerCompleted
NCT00297596Phase 2Updated Oct 28, 2021
Sponsor: SCRI Development Innovations, LLC
Breast Cancer
United States
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective PotentialCompleted
NCT02419378Phase 4Updated Oct 26, 2021
Sponsor: University Hospital Muenster
Multiple Sclerosis, Relapsing-Remitting
Germany
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive LeukemiaTerminated
NCT01158885Phase 2Updated Oct 26, 2021
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium
Minimal Residual Disease · Leukemia, Lymphoblastic, Acute · Leukemia, Myelogenous, Acute
United States
Aflibercept and Chemotherapy as First Line Treatment for Metastatic Colorectal Cancer Assessable With DCE-US (PULSAR).Terminated
NCT02173990Phase 2Updated Oct 20, 2021
Sponsor: Centre Oscar Lambret
Metastatic Colorectal Cancer
France
Effect of Efpeglenatide on Cardiovascular OutcomesTerminated
NCT03496298Phase 3Updated Oct 15, 2021
Sponsor: Sanofi
Type 2 Diabetes Mellitus
United States, Argentina, Bulgaria, Canada, Chile +23 more
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Inception CohortCompleted
NCT02890134N/AUpdated Oct 15, 2021
Sponsor: Fundación Pública Andaluza Progreso y Salud
Systemic Autoimmune Diseases
Belgium, France, Germany, Italy, Spain +1 more
GLP-1-mediated Gluco-metabolic Effects of Bile Acid SequestrationCompleted
NCT03739268NAUpdated Oct 13, 2021
Sponsor: Steno Diabetes Center Copenhagen
Type 2 Diabetes Mellitus
Denmark
Immune Response to COVID-19 Vaccine in Multiple Sclerosis Patients Treated With Teriflunomide and AlemtuzumabUnknown
NCT05075499NAUpdated Oct 12, 2021
Sponsor: Sheba Medical Center
Multiple Sclerosis
Israel
Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric CancerCompleted
NCT00210184Phase 2Updated Oct 6, 2021
Sponsor: Institut Bergonié
Gastric Cancer
France
Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic DermatitisTerminated
NCT03389893Phase 4Updated Oct 4, 2021
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Atopic Dermatitis (AD)
United States
Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric CardiaCompleted
NCT00591123Phase 2Updated Oct 1, 2021
Sponsor: Translational Oncology Research International
Unresectable Adenocarcinoma of the Esophagus · Metastatic Adenocarcinoma of the Esophagus · Unresectable Adenocarcinoma of Gastric Cardia · Metastatic Adenocarcinoma of Gastric Cardia
United States
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction CancerCompleted
NCT00381706Phase 2Updated Sep 29, 2021
Sponsor: Alliance for Clinical Trials in Oncology
Esophageal Cancer
United States
Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19Completed
NCT04315298Phase 2, Phase 3Updated Sep 23, 2021
Sponsor: Regeneron Pharmaceuticals
COVID-19
United States
Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular PrognosisCompleted
NCT02831608Phase 4Updated Sep 22, 2021
Sponsor: Ole Frobert, MD, PhD
Myocardial Infarction · Influenza, Human · Influenza Vaccines · Heart Failure
Australia, Bangladesh, Czechia, Denmark, Latvia +3 more
Ph II Cabazitaxel DD LiposarcomaCompleted
NCT01913652Phase 2Updated Sep 14, 2021
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Dedifferentiated Liposarcoma
Belgium, France, Italy, United Kingdom
Study Evaluating Efficacy and Safety of SAR566658 Treatment in Patients With CA6 Positive Metastatic Triple Negative Breast CancerTerminated
NCT02984683Phase 2Updated Sep 8, 2021
Sponsor: Sanofi
Triple Negative Breast Cancer
Belgium, Czechia, Italy, Netherlands, Spain
European Trial of Immunosuppression in SPK TxCompleted
NCT00140543Phase 3Updated Aug 23, 2021
Sponsor: EUROSPK Study Group
Diabetes Mellitus, Type 1 · Diabetic Nephropathy
Austria, Belgium, Czechia, Germany, Israel +2 more
Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs)Unknown
NCT03050866Phase 2Updated Aug 20, 2021
Sponsor: Erasmus Medical Center
Circulating Tumor Cell · Metastatic Prostate Cancer
Netherlands
Dengue Seroprevalence Study in Blood Donors in the French West IndiesCompleted
NCT01104740N/AUpdated Aug 20, 2021
Sponsor: Etablissement Français du Sang, Martinique
Blood Donors · Dengue
Guadeloupe, Martinique

Previous page Next page